Načítá se...
Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells
Non-alcoholic fatty liver disease is manifested by hepatic accumulation of triglycerides (TG) and is commonly associated with metabolic syndrome. The isoprenoid farnesol (FOH) modulates lipid metabolism and reduces hepatic TG content in rodents. This effect involves activation of at least two nuclea...
Uloženo v:
| Vydáno v: | Toxicol Appl Pharmacol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6349468/ https://ncbi.nlm.nih.gov/pubmed/30611723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.taap.2019.01.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|